380550 — Neurophet Cashflow Statement
0.000.00%
- KR₩246bn
- KR₩247bn
- KR₩2bn
Annual cashflow statement for Neurophet, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | — | 5,263 | -15,101 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | — | -15,891 | 1,080 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -7,931 | 628 | 313 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -7,931 | -8,974 | -12,613 |
| Capital Expenditures | -354 | -313 | -393 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 7,610 | -5,621 | 9,011 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Sale of Intangible Assets | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 7,256 | -5,934 | 8,618 |
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 264 | 19,753 | 342 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -412 | 4,845 | -3,652 |